Odessey R, Goldberg A L
Biochem J. 1979 Feb 15;178(2):475-89. doi: 10.1042/bj1780475.
Since skeletal muscle is the major site in the body for oxidation of leucine, isoleucine and valine, the pathway and control of leucine oxidation were investigated in cell-free preparations of rat muscle. Leucine was found to be transaminated to 4-methyl-2-oxopentanoate, which was then oxidatively decarboxylated. On differential centrifugation 70--80% of the transaminase activity was recovered in the soluble fraction of the cell, and the remaining amount in the mitochondrial fraction. The transaminase, from both fractions had similar pH optima and both were markedly inhibited by Ca2+. Thus changes in cellular Ca2+ concentration may regulate transaminase activity. Both transaminases had a much higher affinity for 2-oxoglutarate than for pyruvate. Therefore the utilization of amino groups from leucine for the biosynthesis of alanine in muscle [Odessey, Khairallah & Goldberg (1974) J. Biol. Chem. 249, 7623--7629] in vivo involves transamination with 2-oxoglutarate to produce glutamate, which is then transaminated with pyruvate to produce alanine. The dehydrogenase activity assayed by the decarboxylation of methyl-2-oxo[1-14C]pentanoate was localized exclusively in the fraction containing mitochondria and required NAD+, CoA and thiamin pyrophosphate for optimal activity. Measurements of competitive inhibition suggested that the oxo acids of leucine, isoleucine and valine are all decarboxylated by the same enzyme. The enzyme activity was decreased by 90% upon freezing or sonication and was stimulated severalfold by Mg2+, K+ and phosphate ions. In addition, it was markedly inhibited by ATP, but not by non-metabolizable analogues. This observation suggests that splitting of ATP is required for inhibition. The oxidative decarboxylation of 4-methyl-2-oxopentanoate by the dehydrogenase appears to be the rate-limiting step for leucine oxidation in muscle homogenates and also in intact tissues. In fact, rat muscles incubated with [1-14C]leucine release 1-14C-labelled oxo acid into the medium at rates comparable with the rate of decarboxylation. Intact muscles also released the oxo acids of [1-14C]valine or [1-14C]isoleucine, but not of other amino acids. These findings suggest that muscle is the primary source of the branched-chain oxo acids found in the blood.
由于骨骼肌是体内亮氨酸、异亮氨酸和缬氨酸氧化的主要部位,因此在大鼠肌肉的无细胞制剂中研究了亮氨酸氧化的途径和调控。发现亮氨酸可转氨生成4-甲基-2-氧代戊酸,然后进行氧化脱羧。差速离心后,70%-80%的转氨酶活性存在于细胞的可溶部分,其余存在于线粒体部分。来自这两个部分的转氨酶具有相似的最适pH值,且均受到Ca2+的显著抑制。因此,细胞内Ca2+浓度的变化可能调节转氨酶活性。两种转氨酶对2-氧代戊二酸的亲和力比对丙酮酸的亲和力高得多。因此,肌肉中亮氨酸的氨基用于丙氨酸生物合成[奥德赛、海拉勒和戈德堡(1974年)《生物化学杂志》249卷,7623-7629页]在体内涉及与2-氧代戊二酸转氨生成谷氨酸,然后谷氨酸再与丙酮酸转氨生成丙氨酸。通过甲基-2-氧代[1-14C]戊酸脱羧测定的脱氢酶活性仅存在于含有线粒体的部分,并且需要NAD+、辅酶A和硫胺焦磷酸才能达到最佳活性。竞争性抑制的测量表明,亮氨酸、异亮氨酸和缬氨酸的氧代酸均由同一种酶脱羧。冷冻或超声处理后,酶活性降低90%,Mg2+、K+和磷酸根离子可使其活性提高几倍。此外,它受到ATP的显著抑制,但不受不可代谢类似物的抑制。这一观察结果表明,ATP的裂解是抑制所必需的。脱氢酶对4-甲基-2-氧代戊酸的氧化脱羧似乎是肌肉匀浆和完整组织中亮氨酸氧化的限速步骤。事实上,用[1-14C]亮氨酸孵育的大鼠肌肉以与脱羧速率相当的速率将1-14C标记的氧代酸释放到培养基中。完整的肌肉也释放[1-14C]缬氨酸或[1-14C]异亮氨酸的氧代酸,但不释放其他氨基酸的氧代酸。这些发现表明,肌肉是血液中支链氧代酸的主要来源。